Slingshot members are tracking this event:

Phase 1b data of Nektar Therapeutics'(NKTR) NKTR-358 in Systemic lupus erythematosus (SLE) due at EULAR June 13, 2019

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks
NKTR Community voting in process
Slingshot Insights Explained
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Nktr-358, Systemic Lupus Erythematous, Eular